References
- C. J. Murray, K. S. Ikuta, F. Sharara, L. Swetschinski, G. Robles Aguilar, A. Gray, C. Han, C. Bisignano, P. Rao, E. Wool, et al., Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet 399(10325) (2022) 629–655; https://doi.org/10.1016/S0140-6736(21)02724-0
- World Health Organization, 2020 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis, WHO, Geneva, April 15, 2021; https://www.who.int/publications-detail-redirect/9789240021303; last access May 25, 2022
- A. Zervosen, E. Sauvage, J. M. Frère, P. Charlier and A. Luxen, Development of new drugs for an old target – the penicillin binding proteins, Molecules 17(11) (2012) 12478–12505; https://doi.org/10.3390/molecules171112478
- P. J. Matteï, D. Neves and A. Dessen, Bridging cell wall biosynthesis and bacterial morphogenesis, Curr. Opin. Struct. Biol. 20(6) (2010) 749–755; https://doi.org/10.1016/j.sbi.2010.09.014
- A. J. Meeske, E. P. Riley, W. P. Robins, T. Uehara, J. J. Mekalanos, D. Kahne, S. Walker, A. C. Kruse, T. G. Bernhardt and D. Z. Rudner, SEDS proteins are a widespread family of bacterial cell wall polymerases, Nature 537(7622) (2016) 634–638; https://doi.org/10.1038/nature19331
- J. F. Fisher, S. O. Meroueh and S. Mobashery, Bacterial resistance to β-lactam antibiotics: compelling opportunism, compelling opportunity, Chem. Rev. 105(2) (2005) 395–424; https://doi.org/10.1021/cr030102i
- E. Sauvage and M. Terrak, Glycosyltransferases and transpeptidases/penicillin-binding proteins: valuable targets for new antibacterials, Antibiotics 5(1) (2016) Article ID 12 (27 pages); https://doi.org/10.3390/antibiotics5010012
- E. Sauvage, F. Kerff, M. Terrak, J. A. Ayala and P. Charlier, The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis, FEMS Microbiol. Rev. 32(2) (2008) 234–258; https://doi.org/10.1111/j.1574-6976.2008.00105.x
- P. Macheboeuf, C. Contreras-Martel, V. Job, O. Dideberg and A. Dessen, Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes, FEMS Microbiol. Rev. 30(5) (2006) 673–691; https://doi.org/10.1111/j.1574-6976.2006.00024.x
- W. Vollmer, D. Blanot and M. A. de Pedro, Peptidoglycan structure and architecture, FEMS Microbiol.Rev.32(2) (2008) 149–167; https://doi.org/10.1111/j.1574-6976.2007.00094.x
- A. Fleming, On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae, Bull. World Health Organ. 79(8) (2001) 780–790.
- E. P. Abraham, E. Chain, C. M. Fletcher, A. D. Gardner, N. G. Heatley, M. A. Jennings and H. W. Florey, Further observations on penicillin, Lancet 238(6155) (1941) 177–189; https://doi.org/10.1016/S0140-6736(00)72122-2
- World Health Organization, WHO Report on Surveillance of Antibiotic Consumption, WHO, Geneva, July 21, 2019; https://www.who.int/publications-detail-redirect/who-report-on-surveillance-of-antibiotic-consumption; last access June 4, 2022
- G. Patrick, An Introduction to Medicinal Chemistry, 6th ed., Oxford University Press, Oxford 2017.
- L. M. Lima, B. N. M. da Silva, G. Barbosa and E. J. Barreiro, β-lactam antibiotics: an overview from a medicinal chemistry perspective, Eur. J. Med. Chem. 208 (2020) Article ID 112829 (21 pages); https://doi.org/10.1016/j.ejmech.2020.112829
- A. Zapun, C. Contreras-Martel and T. Vernet, Penicillin-binding proteins and β-lactam resistance, FEMS Microbiol. Rev. 32(2) (2008) 361–385; https://doi.org/10.1111/j.1574-6976.2007.00095.x
- S. Deketelaere, T. Van Nguyen, C. V. Stevens and M. D’hooghe, Synthetic approaches toward monocyclic 3-amino-β-lactams, ChemistryOpen 6(3) (2017) 301–319; https://doi.org/10.1002/open.201700051
- L. Decuyper, M. Jukič, I. Sosič, A. Žula, M. D’hooghe and S. Gobec, Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams, Med. Res. Rev. 38(2) (2018) 426–503; https://doi.org/10.1002/med.21443
- D. Braga and G. Lackner, One ring to fight them all: the sulfazecin story, Cell Chem. Biol. 24(1) (2017) 1–2; https://doi.org/10.1016/j.chembiol.2017.01.001
- R. B. Sykes and D. P. Bonner, Aztreonam: the first monobactam, Am. J. Med. 78(2) (1985) 2–10; https://doi.org/10.1016/0002-9343(85)90196-2
- F. Reck, A. Bermingham, J. Blais, V. Capka, T. Cariaga, A. Casarez, R. Colvin, C. R. Dean, A. Fekete, W. Gong, E. Growcott, H. Guo, A. K. Jones, C. Li, F. Li, X. Lin, M. Lindvall, S. Lopez, D. McKenney, L. Metzger, H. E. Moser, R. Prathapam, D. Rasper, P. Rudewicz, V. Sethuraman, X. Shen, J. Shaul, R. L. Simmons, K. Tashiro, D. Tang, M. Tjandra, N. Turner, T. Uehara, C. Vitt, S. Whitebread, A. Yifru, X. Zang and Q. Zhu, Optimization of novel monobactams with activity against carbapenem- -resistant Enterobacteriaceae – identification of LYS228, Bioorg. Med. Chem. Lett. 28(4) (2018) 748–755; https://doi.org/10.1016/j.bmcl.2018.01.006
- Z. Fei, Q. Wu, W. Gong, P. Fu, C. Li, X. Wang, Y. Han, B. Li, L. Li, B. Wu, Y. Zhao, J. Li, W. Zhu, W. Qiu, J. Guo, J. Zhou, Y. Li, M. Villa and C. Ming Cheung, Process development for the synthesis of a monobactam antibiotic—LYS228, Org. Process Res. Dev. 24(3) (2020) 363–370; https://doi.org/10.1021/acs.oprd.9b00330
- J. Blais, S. Lopez, C. Li, A. Ruzin, S. Ranjitkar, C. R. Dean, J. A. Leeds, A. Casarez, R. L. Simmons and F. Reck, In vitro activity of LYS228, a novel monobactam antibiotic, against multidrug-resistant Enterobacteriaceae, Antimicrob. Agents Chemother. 62(10) (2018) e00552-18 (10 pages); https://doi.org/10.1128/AAC.00552-18
- K. Grabrijan, N. Strašek and S. Gobec, Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020), Expert Opin. Ther. Pat. 31(3) (2020) 247–266; https://doi.org/10.1080/13543776.2021.1865919
- L. Decuyper, S. Deketelaere, L. Vanparys, M. Jukič, I. Sosič, E. Sauvage, A. M. Amoroso, O. Verlaine, B. Joris, S. Gobec and M. D’hooghe, In silico design and enantioselective synthesis of functionalized monocyclic 3-amino-1-carboxymethyl-β-lactams as inhibitors of penicillin-binding proteins of resistant bacteria, Chem. Eur. J. 24(57) (2018) 15254–15266; https://doi.org/10.1002/chem.201801868
- M. F. Brown, M. J. Mitton-Fry, J. T. Arcari, R. Barham, J. Casavant, B. S. Gerstenberger, S. Han, J. R. Hardink, T. M. Harris, T. Hoang, M. D. Huband, M. S. Lall, M. M. Lemmon, C. Li, J. Lin, S. P. Mc-Curdy, E. McElroy, C. McPherson, E. S. Marr, J. P. Mueller, L. Mullins, A. A. Nikitenko, M. C. Noe, J. Penzien, M. S. Plummer, B. P. Schuff, V. Shanmugasundaram, J. T. Starr, J. Sun, A. Tomaras, J. A. Young and R. P. Zaniewski, Pyridone-conjugated monobactam antibiotics with Gram-negative activity, J. Med. Chem. 56(13) (2013) 5541–5552; https://doi.org/10.1021/jm400560z
- Z. W. Li, X. Lu, Y. X. Wang, X. X. Hu, H. G. Fu, L. M. Gao, X. F. You, S. Tang and D. Q. Song, Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue, Bioorg. Chem. 94 (2020) Article ID 103487 (12 pages); https://doi.org/10.1016/j.bioorg.2019.103487
- L. Tan, Y. Tao, T. Wang, F. Zou, S. Zhang, Q. Kou, A. Niu, Q. Chen, W. Chu, X. Chen, H. Wang and Y. Yang, Discovery of novel pyridone-conjugated monosulfactams as potent and broad-spectrum antibiotics for multidrug-resistant Gram-negative infections, J. Med. Chem. 60(7) (2017) 2669–2684; https://doi.org/10.1021/acs.jmedchem.6b01261
- Q. Kou, T. Wang, F. Zou, S. Zhang, Q. Chen and Y. Yang, Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram--negative bacteria, Eur. J. Med. Chem. 151 (2018) 98–109; https://doi.org/10.1016/j.ejmech.2018.03.058
- G. Patriarca, D. Schiavino, C. Lombardo, G. Altomonte, M. Decinti, A. Buonomo and E. Nucera, Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams, Int. J. Immunopathol. Pharmacol. 21(2) (2008) 375–379; https://doi.org/10.1177/039463200802100215
- W. C. Reygaert, An overview of the antimicrobial resistance mechanisms of bacteria, AIMS Microbiol. 4(3) (2018) 482–501; https://doi.org/10.3934/microbiol.2018.3.482
- B. R. da Cunha, L. P. Fonseca and C. R. C. Calado, Antibiotic discovery: where have we come from, where do we go? Antibiotics 8(2) (2019) Article ID 45 (21 pages); https://doi.org/10.3390/antibiotics8020045
- R. Tommasi, D. G. Brown, G. K. Walkup, J. L. Manchester and A. A. Miller, ESKAPEing the labyrinth of antibacterial discovery, Nat. Rev. Drug Discov. 14 (2015) 529–542; https://doi.org/10.1038/nrd4572
- M. Lakemeyer, W. Zhao, F. A. Mandl, P. Hammann and S. A. Sieber, Thinking outside the box— novel antibacterials to tackle the resistance crisis, Angew. Chem., Int. Ed. 57(44) (2018) 14440–14475; https://doi.org/10.1002/anie.201804971
- World Health Organization, 2021 AWaRe Classification, WHO, Geneva, September 30, 2021; https://www.who.int/publications-detail-redirect/2021-aware-classification; last access October 22, 2022
- M. S. Butler, V. Gigante, H. Sati, S. Paulin, L. Al-Sulaiman, J. H. Rex, P. Fernandes, C. A. Arias, M. Paul, G. E. Thwaites, L. Czaplewski, R. A. Alm, C. Lienhardt, M. Spigelman, L. L. Silver, N. Ohmagari, R. Kozlov, S. Harbarth and P. Beyer, Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed, Antimicrob. Agents Chemother. 66(3) (2022) e01991-21 (20 pages); https://doi.org/10.1128/aac.01991-21
- S. M. Bhavnani, K. M. Krause and P. G. Ambrose, A broken antibiotic market: review of strategies to incentivize drug development, Open Forum Infect. Dis. 7(7) (2020) ofaa083 (6 pages); https://doi.org/10.1093/ofid/ofaa083
- P. Macheboeuf, A. M. Di Guilmi, V. Job, T. Vernet, O. Dideberg and A. Dessen, Active site restructuring regulates ligand recognition in class A penicillin-binding proteins, Proc. Natl. Acad. Sci. USA 102(3) (2005) 577–582; https://doi.org/10.1073/pnas.0407186102
- A. M. di Guilmi, A. Dessen, O. Dideberg and T. Vernet, Functional characterization of penicillin-binding protein 1b from Streptococcus pneumoniae, J. Bacteriol. 185(5) (2003) 1650–1658; https://doi.org/10.1128/JB.185.5.1650-1658.2003
- C. Contreras-Martel, A. Amoroso, E. C. Y. Woon, A. Zervosen, S. Inglis, A. Martins, O. Verlaine, A. M. Rydzik, V. Job, A. Luxen, B. Joris, C. J. Schofield and A. Dessen, Structure-guided design of cell wall biosynthesis inhibitors that overcome β-lactam resistance in Staphylococcus aureus (MRSA), ACS Chem. Biol. 6(9) (2011) 943–951; https://doi.org/10.1021/cb2001846
- H. Newman, A. Krajnc, D. Bellini, C. J. Eyermann, G. A. Boyle, N. G. Paterson, K. E. McAuley, R. Lesniak, M. Gangar, F. von Delft, J. Brem, K. Chibale, C. J. Schofield and C. G. Dowson, High-throughput crystallography reveals boron-containing inhibitors of a penicillin-binding protein with di- and tri-covalent binding modes, J. Med. Chem. 64(15) (2021) 11379–11394; https://doi.org/10.1021/acs.jmedchem.1c00717
- A. Meden, D. Knez, N. Malikowska-Racia, X. Brazzolotto, F. Nachon, J. Svete, K. Sałat, U. Grošelj and S. Gobec, Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors, Eur. J. Med. Chem. 208 (2020) Article ID 112766 (21 pages); https://doi.org/0.1016/j.ejmech.2020.112766
- M. Proj, M. Hrast, D. Knez, K. Bozovičar, K. Grabrijan, A. Meden, S. Gobec and R. Frlan, Fragmentsized thiazoles in fragment-based drug discovery campaigns: friend or foe?, ACS Med. Chem. Lett. 13(12) (2022) 1905–1910; https://doi.org/10.1021/acsmedchemlett.2c00429
- Clinical and Laboratory Standards Institute, M07 – Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (11th ed.), CLSI, Wayne (PA) USA, January 2018; https://clsi.org/media/1928/m07ed11_sample.pdf; last access March 17, 2022
- European Committee on Antimicrobial Susceptibility Testing, EUCAST: Clinical Breakpoints and Dosing of Antibiotics, EUCAST (v 12.0, January 2022); https://www.eucast.org/clinical_breakpoints; last access March 17, 2022
- M. Proj, D. Knez, I. Sosič and S. Gobec, Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds, Drug Discov. Today 27(6) (2022) 1733–1742; https://doi.org/10.1016/j.drudis.2022.03.008
- E. Resnick, A. Bradley, J. Gan, A. Douangamath, T. Krojer, R. Sethi, P. P. Geurink, A. Aimon, G. Amitai, D. Bellini, J. Bennett, M. Fairhead, O. Fedorov, R. Gabizon, J. Gan, J. Guo, A. Plotnikov, N. Reznik, G. F. Ruda, L. Díaz-Sáez, V. M. Straub, T. Szommer, S. Velupillai, D. Zaidman, Y. Zhang, A. R. Coker, C. G. Dowson, H. M. Barr, C. Wang, K. V. M. Huber, P. E. Brennan, H. Ovaa, F. von Delft and N. London, Rapid covalent-probe discovery by electrophile-fragment screening, J. Am. Chem. Soc. 141(22) (2019) 8951–8968; https://doi.org/10.1021/jacs.9b02822
- K. Grabrijan, N. Strašek and S. Gobec, Synthesis of 3-amino-4-substituted monocyclic ß-lactams – Important structural motifs in medicinal chemistry, Int. J. Mol. Sci. 23(1) (2022) Article ID 360 (26 pages); https://doi.org/10.3390/ijms23010360
- S. Carosso, R. Liu, P. A. Miller, S. J. Hecker, T. Glinka and M. J. Miller, Methodology for monobactam diversification: Syntheses and studies of 4-thiomethyl substituted β-lactams with activity against Gram-negative bacteria, including carbapenemase producing Acinetobacter baumannii, J. Med. Chem. 60(21) (2017) 8933–8944; https://doi.org/10.1021/acs.jmedchem.7b01164
- T. Lupia, C. Pallotto, S. Corcione, L. Boglione and F. G. De Rosa, Ceftobiprole perspective: Current and potential future indications, Antibiotics 10(2) (2021) Article ID 170 (11 pages); https://doi.org/10.3390/antibiotics10020170
- A. B. Shapiro, R. F. Gu, N. Gao, S. Livchak and J. Thresher, Continuous fluorescence anisotropy-based assay of BOCILLIN FL penicillin reaction with penicillin binding protein 3, Anal. Biochem. 439(1) (2013) 37–43; https://doi.org/10.1016/j.ab.2013.04.009
- J. S. Martin, C. J. MacKenzie, D. Fletcher and I. H. Gilbert, Characterising covalent warhead reactivity, Bioorg. Med. Chem. 27(10) (2019) 2066–2074; https://doi.org/10.1016/j.bmc.2019.04.002
- A. Urbach, G. Dive, B. Tinant, V. Duval and J. Marchand-Brynaert, Large ring 1,3-bridged 2-azetidinones: Experimental and theoretical studies, Eur. J. Med. Chem. 44(5) (2009) 2071–2080; https://doi.org/10.1016/j.ejmech.2008.10.016
- A. H. Delcour, Outer membrane permeability and antibiotic resistance, Biochim. Biophys. Acta -Proteins Proteomics 1794(5) (2009) 808–816; https://doi.org/10.1016/j.bbapap.2008.11.005
- H. Nikaido, Molecular basis of bacterial outer membrane permeability revisited, Microbiol. Mol. Biol. Rev. 67(4) (2003) 593–656; https://doi.org/10.1128/MMBR.67.4.593-656.2003
- M. Proj, N. Strašek, S. Pajk, D. Knez and I. Sosič, Tunable heteroaromatic nitriles for selective bioorthogonal click reaction with cysteine, Bioconjugate Chem. 34(7) (2023) 1271–1281, https://doi.org/10.1021/acs.bioconjchem.3c00163